nodes	percent_of_prediction	percent_of_DWPC	metapath
Bleomycin—skin cancer—bone cancer	0.453	0.544	CtDrD
Bleomycin—germ cell cancer—bone cancer	0.38	0.456	CtDrD
Bleomycin—LIG1—Mismatch repair—RFC1—bone cancer	0.0117	0.137	CbGpPWpGaD
Bleomycin—Cerebral arteritis—Cisplatin—bone cancer	0.0103	0.126	CcSEcCtD
Bleomycin—LIG1—Gap-filling DNA repair synthesis and ligation in GG-NER—RFC1—bone cancer	0.00706	0.0822	CbGpPWpGaD
Bleomycin—LIG1—Lagging Strand Synthesis—RFC1—bone cancer	0.00596	0.0694	CbGpPWpGaD
Bleomycin—LIG1—Telomere C-strand (Lagging Strand) Synthesis—RFC1—bone cancer	0.00554	0.0646	CbGpPWpGaD
Bleomycin—Thrombotic microangiopathy—Cisplatin—bone cancer	0.00494	0.0607	CcSEcCtD
Bleomycin—LIG1—Extension of Telomeres—RFC1—bone cancer	0.0046	0.0536	CbGpPWpGaD
Bleomycin—LIG1—DNA strand elongation—RFC1—bone cancer	0.00425	0.0496	CbGpPWpGaD
Bleomycin—LIG1—Global Genomic NER (GG-NER)—RFC1—bone cancer	0.00405	0.0472	CbGpPWpGaD
Bleomycin—LIG3—DNA Repair—RFC1—bone cancer	0.004	0.0466	CbGpPWpGaD
Bleomycin—LIG1—Transcription-coupled NER (TC-NER)—RFC1—bone cancer	0.00324	0.0377	CbGpPWpGaD
Bleomycin—LIG1—Homologous Recombination Repair—BRCA2—bone cancer	0.0031	0.0361	CbGpPWpGaD
Bleomycin—LIG1—Nucleotide Excision Repair—RFC1—bone cancer	0.00298	0.0347	CbGpPWpGaD
Bleomycin—Lung fibrosis interstitial—Methotrexate—bone cancer	0.00295	0.0362	CcSEcCtD
Bleomycin—LIG1—Double-Strand Break Repair—BRCA2—bone cancer	0.00243	0.0283	CbGpPWpGaD
Bleomycin—Extravasation—Carboplatin—bone cancer	0.00242	0.0297	CcSEcCtD
Bleomycin—Nail changes—Methotrexate—bone cancer	0.00234	0.0288	CcSEcCtD
Bleomycin—Dry cough—Methotrexate—bone cancer	0.0022	0.027	CcSEcCtD
Bleomycin—LIG1—Telomere Maintenance—RFC1—bone cancer	0.00209	0.0243	CbGpPWpGaD
Bleomycin—Phlebitis—Carboplatin—bone cancer	0.00178	0.0219	CcSEcCtD
Bleomycin—LIG1—Synthesis of DNA—RFC1—bone cancer	0.00177	0.0206	CbGpPWpGaD
Bleomycin—LIG3—DNA Repair—BRCA2—bone cancer	0.00175	0.0204	CbGpPWpGaD
Bleomycin—LIG1—Chromosome Maintenance—RFC1—bone cancer	0.00174	0.0202	CbGpPWpGaD
Bleomycin—LIG1—DNA Replication—RFC1—bone cancer	0.00166	0.0193	CbGpPWpGaD
Bleomycin—Cystitis haemorrhagic—Epirubicin—bone cancer	0.00159	0.0195	CcSEcCtD
Bleomycin—LIG1—DNA Repair—RFC1—bone cancer	0.00155	0.0181	CbGpPWpGaD
Bleomycin—Cystitis haemorrhagic—Doxorubicin—bone cancer	0.00147	0.018	CcSEcCtD
Bleomycin—LIG1—S Phase—RFC1—bone cancer	0.00145	0.0169	CbGpPWpGaD
Bleomycin—Myelosuppression—Cisplatin—bone cancer	0.00132	0.0162	CcSEcCtD
Bleomycin—Nephropathy toxic—Cisplatin—bone cancer	0.00108	0.0132	CcSEcCtD
Bleomycin—Febrile neutropenia—Cisplatin—bone cancer	0.00103	0.0126	CcSEcCtD
Bleomycin—Rales—Methotrexate—bone cancer	0.000829	0.0102	CcSEcCtD
Bleomycin—Pulmonary fibrosis—Methotrexate—bone cancer	0.000773	0.00949	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000759	0.00885	CbGpPWpGaD
Bleomycin—Infection—Carboplatin—bone cancer	0.000749	0.00919	CcSEcCtD
Bleomycin—Lung infiltration—Methotrexate—bone cancer	0.000725	0.0089	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—ZW10—bone cancer	0.000718	0.00836	CbGpPWpGaD
Bleomycin—Extravasation—Cisplatin—bone cancer	0.000711	0.00872	CcSEcCtD
Bleomycin—Tenderness—Cisplatin—bone cancer	0.000711	0.00872	CcSEcCtD
Bleomycin—LIG1—DNA Repair—BRCA2—bone cancer	0.000681	0.00793	CbGpPWpGaD
Bleomycin—Myelosuppression—Epirubicin—bone cancer	0.000679	0.00833	CcSEcCtD
Bleomycin—Ulcer—Cisplatin—bone cancer	0.000655	0.00804	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000645	0.00752	CbGpPWpGaD
Bleomycin—Pain—Carboplatin—bone cancer	0.000645	0.00791	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—ZW10—bone cancer	0.000642	0.00748	CbGpPWpGaD
Bleomycin—Myelosuppression—Doxorubicin—bone cancer	0.000628	0.00771	CcSEcCtD
Bleomycin—Mucosal inflammation—Methotrexate—bone cancer	0.000614	0.00754	CcSEcCtD
Bleomycin—Wheezing—Cisplatin—bone cancer	0.000602	0.00739	CcSEcCtD
Bleomycin—Body temperature increased—Carboplatin—bone cancer	0.000596	0.00731	CcSEcCtD
Bleomycin—Skin exfoliation—Cisplatin—bone cancer	0.000592	0.00726	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000588	0.00685	CbGpPWpGaD
Bleomycin—Mucosal inflammation—Epirubicin—bone cancer	0.000575	0.00706	CcSEcCtD
Bleomycin—Local reaction—Epirubicin—bone cancer	0.000575	0.00706	CcSEcCtD
Bleomycin—Skin hyperpigmentation—Methotrexate—bone cancer	0.000572	0.00702	CcSEcCtD
Bleomycin—Febrile neutropenia—Methotrexate—bone cancer	0.000565	0.00694	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—TUBB4B—bone cancer	0.000544	0.00634	CbGpPWpGaD
Bleomycin—Skin hyperpigmentation—Epirubicin—bone cancer	0.000535	0.00657	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000535	0.00624	CbGpPWpGaD
Bleomycin—Mucosal inflammation—Doxorubicin—bone cancer	0.000532	0.00653	CcSEcCtD
Bleomycin—Local reaction—Doxorubicin—bone cancer	0.000532	0.00653	CcSEcCtD
Bleomycin—Febrile neutropenia—Epirubicin—bone cancer	0.000529	0.00649	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000528	0.00615	CbGpPWpGaD
Bleomycin—Nail disorder—Methotrexate—bone cancer	0.000524	0.00644	CcSEcCtD
Bleomycin—Phlebitis—Cisplatin—bone cancer	0.000522	0.00641	CcSEcCtD
Bleomycin—Hypomagnesaemia—Epirubicin—bone cancer	0.000501	0.00615	CcSEcCtD
Bleomycin—LIG1—Synthesis of DNA—RB1—bone cancer	0.0005	0.00583	CbGpPWpGaD
Bleomycin—Skin hyperpigmentation—Doxorubicin—bone cancer	0.000495	0.00608	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—RFC1—bone cancer	0.000493	0.00575	CbGpPWpGaD
Bleomycin—Nail disorder—Epirubicin—bone cancer	0.000491	0.00602	CcSEcCtD
Bleomycin—Febrile neutropenia—Doxorubicin—bone cancer	0.00049	0.00601	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—TUBB4B—bone cancer	0.000486	0.00567	CbGpPWpGaD
Bleomycin—Interstitial lung disease—Methotrexate—bone cancer	0.000481	0.0059	CcSEcCtD
Bleomycin—LIG1—S Phase—CDK4—bone cancer	0.000472	0.0055	CbGpPWpGaD
Bleomycin—LIG1—DNA Replication—RB1—bone cancer	0.000469	0.00547	CbGpPWpGaD
Bleomycin—Hypomagnesaemia—Doxorubicin—bone cancer	0.000464	0.00569	CcSEcCtD
Bleomycin—Cerebrovascular accident—Cisplatin—bone cancer	0.000459	0.00563	CcSEcCtD
Bleomycin—Nail disorder—Doxorubicin—bone cancer	0.000454	0.00557	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000447	0.00521	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle—RFC1—bone cancer	0.000441	0.00514	CbGpPWpGaD
Bleomycin—LIG1—S Phase—RB1—bone cancer	0.00041	0.00478	CbGpPWpGaD
Bleomycin—Hyperaesthesia—Epirubicin—bone cancer	0.000406	0.00498	CcSEcCtD
Bleomycin—Extravasation—Methotrexate—bone cancer	0.00039	0.00478	CcSEcCtD
Bleomycin—Hyperaesthesia—Doxorubicin—bone cancer	0.000375	0.00461	CcSEcCtD
Bleomycin—Pancytopenia—Cisplatin—bone cancer	0.000369	0.00453	CcSEcCtD
Bleomycin—Extravasation—Epirubicin—bone cancer	0.000365	0.00448	CcSEcCtD
Bleomycin—Ulcer—Methotrexate—bone cancer	0.00036	0.00441	CcSEcCtD
Bleomycin—Acute coronary syndrome—Cisplatin—bone cancer	0.000342	0.00419	CcSEcCtD
Bleomycin—Myocardial infarction—Cisplatin—bone cancer	0.00034	0.00417	CcSEcCtD
Bleomycin—Stomatitis—Cisplatin—bone cancer	0.000338	0.00415	CcSEcCtD
Bleomycin—Extravasation—Doxorubicin—bone cancer	0.000338	0.00414	CcSEcCtD
Bleomycin—Ulcer—Epirubicin—bone cancer	0.000337	0.00413	CcSEcCtD
Bleomycin—Cystitis noninfective—Methotrexate—bone cancer	0.000332	0.00408	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000332	0.00387	CbGpPWpGaD
Bleomycin—Cystitis—Methotrexate—bone cancer	0.000328	0.00403	CcSEcCtD
Bleomycin—Skin exfoliation—Methotrexate—bone cancer	0.000325	0.00399	CcSEcCtD
Bleomycin—Ulcer—Doxorubicin—bone cancer	0.000311	0.00382	CcSEcCtD
Bleomycin—Cystitis noninfective—Epirubicin—bone cancer	0.000311	0.00382	CcSEcCtD
Bleomycin—Bladder pain—Methotrexate—bone cancer	0.000308	0.00377	CcSEcCtD
Bleomycin—Cystitis—Epirubicin—bone cancer	0.000307	0.00377	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—DHFR—bone cancer	0.000306	0.00356	CbGpPWpGaD
Bleomycin—Skin exfoliation—Epirubicin—bone cancer	0.000304	0.00373	CcSEcCtD
Bleomycin—BLMH—Immune System—ATF1—bone cancer	0.000303	0.00353	CbGpPWpGaD
Bleomycin—BLMH—Immune System—IL3—bone cancer	0.000296	0.00345	CbGpPWpGaD
Bleomycin—Flushing—Cisplatin—bone cancer	0.000289	0.00355	CcSEcCtD
Bleomycin—Bladder pain—Epirubicin—bone cancer	0.000288	0.00353	CcSEcCtD
Bleomycin—Cystitis noninfective—Doxorubicin—bone cancer	0.000288	0.00353	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—KIT—bone cancer	0.000285	0.00332	CbGpPWpGaD
Bleomycin—Cystitis—Doxorubicin—bone cancer	0.000284	0.00349	CcSEcCtD
Bleomycin—Skin exfoliation—Doxorubicin—bone cancer	0.000281	0.00345	CcSEcCtD
Bleomycin—Alopecia—Cisplatin—bone cancer	0.000275	0.00338	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—DHFR—bone cancer	0.000273	0.00319	CbGpPWpGaD
Bleomycin—Erythema—Cisplatin—bone cancer	0.000271	0.00333	CcSEcCtD
Bleomycin—Phlebitis—Epirubicin—bone cancer	0.000268	0.00329	CcSEcCtD
Bleomycin—Bladder pain—Doxorubicin—bone cancer	0.000266	0.00327	CcSEcCtD
Bleomycin—Cerebrovascular accident—Methotrexate—bone cancer	0.000252	0.00309	CcSEcCtD
Bleomycin—Ill-defined disorder—Cisplatin—bone cancer	0.000251	0.00309	CcSEcCtD
Bleomycin—Anaemia—Cisplatin—bone cancer	0.00025	0.00307	CcSEcCtD
Bleomycin—Phlebitis—Doxorubicin—bone cancer	0.000248	0.00305	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.000246	0.00287	CbGpPWpGaD
Bleomycin—Malaise—Cisplatin—bone cancer	0.000244	0.003	CcSEcCtD
Bleomycin—Leukopenia—Cisplatin—bone cancer	0.000243	0.00298	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.000237	0.00276	CbGpPWpGaD
Bleomycin—Cerebrovascular accident—Epirubicin—bone cancer	0.000236	0.00289	CcSEcCtD
Bleomycin—Myalgia—Cisplatin—bone cancer	0.000231	0.00283	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—CHEK2—bone cancer	0.000229	0.00266	CbGpPWpGaD
Bleomycin—Discomfort—Cisplatin—bone cancer	0.000228	0.0028	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—MDM2—bone cancer	0.000224	0.00261	CbGpPWpGaD
Bleomycin—Oedema—Cisplatin—bone cancer	0.000221	0.00271	CcSEcCtD
Bleomycin—Anaphylactic shock—Cisplatin—bone cancer	0.000221	0.00271	CcSEcCtD
Bleomycin—Infection—Cisplatin—bone cancer	0.00022	0.0027	CcSEcCtD
Bleomycin—Cerebrovascular accident—Doxorubicin—bone cancer	0.000218	0.00268	CcSEcCtD
Bleomycin—Thrombocytopenia—Cisplatin—bone cancer	0.000217	0.00266	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.000214	0.00249	CbGpPWpGaD
Bleomycin—Anorexia—Cisplatin—bone cancer	0.000211	0.00259	CcSEcCtD
Bleomycin—Hypotension—Cisplatin—bone cancer	0.000207	0.00254	CcSEcCtD
Bleomycin—Pancytopenia—Methotrexate—bone cancer	0.000203	0.00249	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000202	0.00247	CcSEcCtD
Bleomycin—Paraesthesia—Cisplatin—bone cancer	0.000199	0.00244	CcSEcCtD
Bleomycin—Dyspnoea—Cisplatin—bone cancer	0.000197	0.00242	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—BRCA2—bone cancer	0.000194	0.00226	CbGpPWpGaD
Bleomycin—Decreased appetite—Cisplatin—bone cancer	0.000192	0.00236	CcSEcCtD
Bleomycin—Pneumonia—Methotrexate—bone cancer	0.000191	0.00235	CcSEcCtD
Bleomycin—Pancytopenia—Epirubicin—bone cancer	0.00019	0.00233	CcSEcCtD
Bleomycin—Pain—Cisplatin—bone cancer	0.000189	0.00232	CcSEcCtD
Bleomycin—Stomatitis—Methotrexate—bone cancer	0.000185	0.00228	CcSEcCtD
Bleomycin—Feeling abnormal—Cisplatin—bone cancer	0.000182	0.00224	CcSEcCtD
Bleomycin—Haematuria—Methotrexate—bone cancer	0.000181	0.00223	CcSEcCtD
Bleomycin—Weight decreased—Epirubicin—bone cancer	0.000181	0.00222	CcSEcCtD
Bleomycin—Pneumonia—Epirubicin—bone cancer	0.000179	0.0022	CcSEcCtD
Bleomycin—Pancytopenia—Doxorubicin—bone cancer	0.000176	0.00215	CcSEcCtD
Bleomycin—Body temperature increased—Cisplatin—bone cancer	0.000175	0.00215	CcSEcCtD
Bleomycin—Stomatitis—Epirubicin—bone cancer	0.000174	0.00213	CcSEcCtD
Bleomycin—BLMH—Immune System—KIT—bone cancer	0.000173	0.00201	CbGpPWpGaD
Bleomycin—Haemoglobin—Methotrexate—bone cancer	0.000172	0.00211	CcSEcCtD
Bleomycin—Haemorrhage—Methotrexate—bone cancer	0.000171	0.0021	CcSEcCtD
Bleomycin—Haematuria—Epirubicin—bone cancer	0.00017	0.00208	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.000168	0.00196	CbGpPWpGaD
Bleomycin—Weight decreased—Doxorubicin—bone cancer	0.000167	0.00205	CcSEcCtD
Bleomycin—Pneumonia—Doxorubicin—bone cancer	0.000166	0.00203	CcSEcCtD
Bleomycin—Hypersensitivity—Cisplatin—bone cancer	0.000163	0.002	CcSEcCtD
Bleomycin—Haemoglobin—Epirubicin—bone cancer	0.000161	0.00197	CcSEcCtD
Bleomycin—LIG1—Cell Cycle, Mitotic—CDK4—bone cancer	0.000161	0.00187	CbGpPWpGaD
Bleomycin—Stomatitis—Doxorubicin—bone cancer	0.000161	0.00197	CcSEcCtD
Bleomycin—Haemorrhage—Epirubicin—bone cancer	0.00016	0.00196	CcSEcCtD
Bleomycin—Hypoaesthesia—Epirubicin—bone cancer	0.000159	0.00195	CcSEcCtD
Bleomycin—Asthenia—Cisplatin—bone cancer	0.000159	0.00195	CcSEcCtD
Bleomycin—Haematuria—Doxorubicin—bone cancer	0.000157	0.00193	CcSEcCtD
Bleomycin—Chills—Methotrexate—bone cancer	0.000153	0.00188	CcSEcCtD
Bleomycin—BLMH—Adaptive Immune System—EGFR—bone cancer	0.000153	0.00178	CbGpPWpGaD
Bleomycin—LIG1—Disease—ENO2—bone cancer	0.000151	0.00176	CbGpPWpGaD
Bleomycin—Alopecia—Methotrexate—bone cancer	0.000151	0.00185	CcSEcCtD
Bleomycin—Erythema—Methotrexate—bone cancer	0.000149	0.00182	CcSEcCtD
Bleomycin—Haemoglobin—Doxorubicin—bone cancer	0.000149	0.00182	CcSEcCtD
Bleomycin—Flushing—Epirubicin—bone cancer	0.000148	0.00182	CcSEcCtD
Bleomycin—Haemorrhage—Doxorubicin—bone cancer	0.000148	0.00182	CcSEcCtD
Bleomycin—Hypoaesthesia—Doxorubicin—bone cancer	0.000147	0.00181	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—CDK4—bone cancer	0.000144	0.00167	CbGpPWpGaD
Bleomycin—Chills—Epirubicin—bone cancer	0.000143	0.00176	CcSEcCtD
Bleomycin—Alopecia—Epirubicin—bone cancer	0.000141	0.00173	CcSEcCtD
Bleomycin—LIG1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.000141	0.00164	CbGpPWpGaD
Bleomycin—Vomiting—Cisplatin—bone cancer	0.000141	0.00173	CcSEcCtD
Bleomycin—LIG1—Disease—DHFR—bone cancer	0.00014	0.00163	CbGpPWpGaD
Bleomycin—LIG1—Cell Cycle, Mitotic—RB1—bone cancer	0.00014	0.00163	CbGpPWpGaD
Bleomycin—Rash—Cisplatin—bone cancer	0.000139	0.00171	CcSEcCtD
Bleomycin—Dermatitis—Cisplatin—bone cancer	0.000139	0.00171	CcSEcCtD
Bleomycin—Erythema—Epirubicin—bone cancer	0.000139	0.00171	CcSEcCtD
Bleomycin—Ill-defined disorder—Methotrexate—bone cancer	0.000138	0.00169	CcSEcCtD
Bleomycin—Anaemia—Methotrexate—bone cancer	0.000137	0.00169	CcSEcCtD
Bleomycin—Flushing—Doxorubicin—bone cancer	0.000137	0.00168	CcSEcCtD
Bleomycin—BLMH—Immune System—MDM2—bone cancer	0.000136	0.00158	CbGpPWpGaD
Bleomycin—Malaise—Methotrexate—bone cancer	0.000134	0.00165	CcSEcCtD
Bleomycin—Leukopenia—Methotrexate—bone cancer	0.000133	0.00163	CcSEcCtD
Bleomycin—Chills—Doxorubicin—bone cancer	0.000133	0.00163	CcSEcCtD
Bleomycin—Nausea—Cisplatin—bone cancer	0.000131	0.00161	CcSEcCtD
Bleomycin—Alopecia—Doxorubicin—bone cancer	0.000131	0.0016	CcSEcCtD
Bleomycin—Cough—Methotrexate—bone cancer	0.00013	0.00159	CcSEcCtD
Bleomycin—Ill-defined disorder—Epirubicin—bone cancer	0.000129	0.00158	CcSEcCtD
Bleomycin—Erythema—Doxorubicin—bone cancer	0.000129	0.00158	CcSEcCtD
Bleomycin—Anaemia—Epirubicin—bone cancer	0.000129	0.00158	CcSEcCtD
Bleomycin—Chest pain—Methotrexate—bone cancer	0.000127	0.00155	CcSEcCtD
Bleomycin—Myalgia—Methotrexate—bone cancer	0.000127	0.00155	CcSEcCtD
Bleomycin—Malaise—Epirubicin—bone cancer	0.000125	0.00154	CcSEcCtD
Bleomycin—Discomfort—Methotrexate—bone cancer	0.000125	0.00153	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—RB1—bone cancer	0.000125	0.00146	CbGpPWpGaD
Bleomycin—Leukopenia—Epirubicin—bone cancer	0.000125	0.00153	CcSEcCtD
Bleomycin—Confusional state—Methotrexate—bone cancer	0.000122	0.0015	CcSEcCtD
Bleomycin—Cough—Epirubicin—bone cancer	0.000121	0.00149	CcSEcCtD
Bleomycin—Anaphylactic shock—Methotrexate—bone cancer	0.000121	0.00149	CcSEcCtD
Bleomycin—Infection—Methotrexate—bone cancer	0.000121	0.00148	CcSEcCtD
Bleomycin—Ill-defined disorder—Doxorubicin—bone cancer	0.000119	0.00147	CcSEcCtD
Bleomycin—Anaemia—Doxorubicin—bone cancer	0.000119	0.00146	CcSEcCtD
Bleomycin—Thrombocytopenia—Methotrexate—bone cancer	0.000119	0.00146	CcSEcCtD
Bleomycin—Chest pain—Epirubicin—bone cancer	0.000118	0.00145	CcSEcCtD
Bleomycin—Myalgia—Epirubicin—bone cancer	0.000118	0.00145	CcSEcCtD
Bleomycin—BLMH—Immune System—JUN—bone cancer	0.000118	0.00138	CbGpPWpGaD
Bleomycin—Discomfort—Epirubicin—bone cancer	0.000117	0.00144	CcSEcCtD
Bleomycin—Malaise—Doxorubicin—bone cancer	0.000116	0.00142	CcSEcCtD
Bleomycin—Anorexia—Methotrexate—bone cancer	0.000116	0.00142	CcSEcCtD
Bleomycin—Leukopenia—Doxorubicin—bone cancer	0.000115	0.00141	CcSEcCtD
Bleomycin—Confusional state—Epirubicin—bone cancer	0.000115	0.00141	CcSEcCtD
Bleomycin—Anaphylactic shock—Epirubicin—bone cancer	0.000114	0.00139	CcSEcCtD
Bleomycin—Oedema—Epirubicin—bone cancer	0.000114	0.00139	CcSEcCtD
Bleomycin—Hypotension—Methotrexate—bone cancer	0.000113	0.00139	CcSEcCtD
Bleomycin—Infection—Epirubicin—bone cancer	0.000113	0.00138	CcSEcCtD
Bleomycin—Cough—Doxorubicin—bone cancer	0.000112	0.00138	CcSEcCtD
Bleomycin—Thrombocytopenia—Epirubicin—bone cancer	0.000111	0.00136	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000111	0.00136	CcSEcCtD
Bleomycin—Chest pain—Doxorubicin—bone cancer	0.00011	0.00135	CcSEcCtD
Bleomycin—Myalgia—Doxorubicin—bone cancer	0.00011	0.00135	CcSEcCtD
Bleomycin—Paraesthesia—Methotrexate—bone cancer	0.000109	0.00134	CcSEcCtD
Bleomycin—Discomfort—Doxorubicin—bone cancer	0.000108	0.00133	CcSEcCtD
Bleomycin—Anorexia—Epirubicin—bone cancer	0.000108	0.00133	CcSEcCtD
Bleomycin—Dyspnoea—Methotrexate—bone cancer	0.000108	0.00133	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—MDM2—bone cancer	0.000106	0.00124	CbGpPWpGaD
Bleomycin—Hypotension—Epirubicin—bone cancer	0.000106	0.0013	CcSEcCtD
Bleomycin—Confusional state—Doxorubicin—bone cancer	0.000106	0.0013	CcSEcCtD
Bleomycin—Decreased appetite—Methotrexate—bone cancer	0.000106	0.00129	CcSEcCtD
Bleomycin—Oedema—Doxorubicin—bone cancer	0.000105	0.00129	CcSEcCtD
Bleomycin—Anaphylactic shock—Doxorubicin—bone cancer	0.000105	0.00129	CcSEcCtD
Bleomycin—Infection—Doxorubicin—bone cancer	0.000104	0.00128	CcSEcCtD
Bleomycin—Pain—Methotrexate—bone cancer	0.000104	0.00127	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000103	0.00127	CcSEcCtD
Bleomycin—Thrombocytopenia—Doxorubicin—bone cancer	0.000103	0.00126	CcSEcCtD
Bleomycin—Paraesthesia—Epirubicin—bone cancer	0.000102	0.00125	CcSEcCtD
Bleomycin—LIG1—Disease—TGFBR2—bone cancer	0.000102	0.00118	CbGpPWpGaD
Bleomycin—Dyspnoea—Epirubicin—bone cancer	0.000101	0.00124	CcSEcCtD
Bleomycin—Anorexia—Doxorubicin—bone cancer	0.0001	0.00123	CcSEcCtD
Bleomycin—Feeling abnormal—Methotrexate—bone cancer	0.0001	0.00123	CcSEcCtD
Bleomycin—Decreased appetite—Epirubicin—bone cancer	9.87e-05	0.00121	CcSEcCtD
Bleomycin—Hypotension—Doxorubicin—bone cancer	9.82e-05	0.0012	CcSEcCtD
Bleomycin—Pain—Epirubicin—bone cancer	9.71e-05	0.00119	CcSEcCtD
Bleomycin—Urticaria—Methotrexate—bone cancer	9.64e-05	0.00118	CcSEcCtD
Bleomycin—Body temperature increased—Methotrexate—bone cancer	9.59e-05	0.00118	CcSEcCtD
Bleomycin—Musculoskeletal discomfort—Doxorubicin—bone cancer	9.57e-05	0.00117	CcSEcCtD
Bleomycin—Paraesthesia—Doxorubicin—bone cancer	9.44e-05	0.00116	CcSEcCtD
Bleomycin—Dyspnoea—Doxorubicin—bone cancer	9.37e-05	0.00115	CcSEcCtD
Bleomycin—Feeling abnormal—Epirubicin—bone cancer	9.36e-05	0.00115	CcSEcCtD
Bleomycin—BLMH—Immune System—EGFR—bone cancer	9.29e-05	0.00108	CbGpPWpGaD
Bleomycin—Decreased appetite—Doxorubicin—bone cancer	9.14e-05	0.00112	CcSEcCtD
Bleomycin—Urticaria—Epirubicin—bone cancer	9.02e-05	0.00111	CcSEcCtD
Bleomycin—Pain—Doxorubicin—bone cancer	8.99e-05	0.0011	CcSEcCtD
Bleomycin—Body temperature increased—Epirubicin—bone cancer	8.98e-05	0.0011	CcSEcCtD
Bleomycin—Hypersensitivity—Methotrexate—bone cancer	8.94e-05	0.0011	CcSEcCtD
Bleomycin—Asthenia—Methotrexate—bone cancer	8.71e-05	0.00107	CcSEcCtD
Bleomycin—Feeling abnormal—Doxorubicin—bone cancer	8.66e-05	0.00106	CcSEcCtD
Bleomycin—Pruritus—Methotrexate—bone cancer	8.59e-05	0.00105	CcSEcCtD
Bleomycin—Hypersensitivity—Epirubicin—bone cancer	8.37e-05	0.00103	CcSEcCtD
Bleomycin—Urticaria—Doxorubicin—bone cancer	8.35e-05	0.00102	CcSEcCtD
Bleomycin—Body temperature increased—Doxorubicin—bone cancer	8.31e-05	0.00102	CcSEcCtD
Bleomycin—Asthenia—Epirubicin—bone cancer	8.15e-05	0.001	CcSEcCtD
Bleomycin—Pruritus—Epirubicin—bone cancer	8.04e-05	0.000986	CcSEcCtD
Bleomycin—Hypersensitivity—Doxorubicin—bone cancer	7.74e-05	0.00095	CcSEcCtD
Bleomycin—Vomiting—Methotrexate—bone cancer	7.72e-05	0.000947	CcSEcCtD
Bleomycin—Rash—Methotrexate—bone cancer	7.65e-05	0.000939	CcSEcCtD
Bleomycin—Dermatitis—Methotrexate—bone cancer	7.65e-05	0.000938	CcSEcCtD
Bleomycin—Asthenia—Doxorubicin—bone cancer	7.54e-05	0.000925	CcSEcCtD
Bleomycin—Pruritus—Doxorubicin—bone cancer	7.44e-05	0.000912	CcSEcCtD
Bleomycin—Vomiting—Epirubicin—bone cancer	7.22e-05	0.000886	CcSEcCtD
Bleomycin—Nausea—Methotrexate—bone cancer	7.21e-05	0.000885	CcSEcCtD
Bleomycin—Rash—Epirubicin—bone cancer	7.16e-05	0.000879	CcSEcCtD
Bleomycin—Dermatitis—Epirubicin—bone cancer	7.15e-05	0.000878	CcSEcCtD
Bleomycin—LIG1—Disease—KIT—bone cancer	6.94e-05	0.000808	CbGpPWpGaD
Bleomycin—Nausea—Epirubicin—bone cancer	6.75e-05	0.000828	CcSEcCtD
Bleomycin—Vomiting—Doxorubicin—bone cancer	6.68e-05	0.00082	CcSEcCtD
Bleomycin—Rash—Doxorubicin—bone cancer	6.63e-05	0.000813	CcSEcCtD
Bleomycin—Dermatitis—Doxorubicin—bone cancer	6.62e-05	0.000812	CcSEcCtD
Bleomycin—LIG1—Disease—BRAF—bone cancer	6.52e-05	0.00076	CbGpPWpGaD
Bleomycin—Nausea—Doxorubicin—bone cancer	6.24e-05	0.000766	CcSEcCtD
Bleomycin—LIG1—Cell Cycle—TP53—bone cancer	6.11e-05	0.000712	CbGpPWpGaD
Bleomycin—LIG1—Disease—MDM2—bone cancer	5.46e-05	0.000636	CbGpPWpGaD
Bleomycin—LIG1—Disease—PTGS2—bone cancer	5.27e-05	0.000614	CbGpPWpGaD
Bleomycin—LIG1—Disease—EGFR—bone cancer	3.73e-05	0.000435	CbGpPWpGaD
